Ebet Inc
Change company Symbol lookup
Select an option...
EBET Ebet Inc
VIVHY Vivendi SE
PDI PIMCO Dynamic Income Fund
BXRX Baudax Bio Inc
BAC Bank of America Corp
SPRU Spruce Power Holding Corp
SRNEQ Sorrento Therapeutics Inc
SPI SPI Energy Co Ltd
AMC AMC Entertainment Holdings Inc
BOF BranchOut Food Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Consumer Discretionary : Hotels, Restaurants & Leisure | Small Cap Growth
Company profile

EBET, Inc. operates platforms to provide a real money online gambling experience focused on i-gaming including casino, sportsbook and esports events. The Company operates under a Curacao gaming sublicense and under a strategic partnership with Aspire Global plc (Aspire) allowing the Company to provide online betting services to various countries around the world. The Company operates online casino and sportsbook brands consisting of Karamba, Hopa, Griffon Casino, BetTarget, Dansk777, and GenerationVIP. It operates seven online wagering brands, through Websites and mobile applications, where it accepts deposits and funds from its customers and offer its customers the ability to use those funds to wager on slot and table games, live casino games as well as virtual sport computer simulated games and sports betting. It has market access for its esports products in various regulated markets, including the United Kingdom, Germany, Ireland, Malta, and Denmark, among others.

Closing Price
Day's Change
-0.0202 (-39.00%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Canopy Growth's BioSteel sports drink unit files for bankruptcy in a move to stem cash burn

10:58 am ET September 14, 2023 (MarketWatch)

By Steve Gelsi

Canopy Growth continues to focus on its core cannabis business by shedding its sports-drink unit BioSteel.

Canopy Growth Corp. is announcing a bankruptcy filing for its BioSteel sports drink in Canada and the U.S. on Thursday in a move by the cannabis company to strengthen its financial position, MarketWatch has learned.

Canopy Growth Corp. (WEED.T) has ceased funding BioSteel, which rang up about C$32.5 million ($24 million) in sales in the company's fiscal first quarter.

Canopy Growth's stock was up 17% on Thursday, on the heels of losses in recent sessions. The stock is up about 239% in the past month after the U.S. Department of Health and Human Services to move cannabis to a Schedule III classification from Schedule I.

The BioSteel filing "immediately eliminates significant cash burn for Canopy Growth and provides for an orderly realization...through a sales process," the company said.

As BioSteel's senior secured lender, Canopy said it plans to recover proceeds from a bankruptcy sale.

BioSteel has begun proceedings under the Companies' Creditors Arrangement Act (CCAA) in the Ontario Superior Court of Justice and will also seek protection from creditors under Chapter 15 of the U.S. Bankruptcy Code for parties of interest involving more than one country.

In a statement, Canopy Growth Chief Executive David Klein said the BioSteel bankruptcy marks a "major milestone" in the company's plan to generate adjusted earnings before interest, taxes, depreciation and amortization by the end of fiscal 2024.

With year-over-year revenue growth for BioSteel, "we believe the brand remains an attractive asset, [but] it does not align with Canopy Growth's cannabis-focused asset-light strategy," Klein said.

Canopy Growth's auditor in June disclosed that it has "substantial doubt about its ability to continue as a going concern" after a series of money-losing quarters. It also launched a strategic review of BioSteel at that time.

Canopy Growth cut 1,200 jobs in 2022 and 2023 as it shifted to an asset-light business model.

Also read:Canopy Growth faces SEC investigation after BioSteel sales misstatements

BioSteel "is a great brand," but that type of consumer-packaged goods requires "a lot of investment to grow" and it's not the best fit for a cannabis company, Canopy Growth CEO David Klein told MarketWatch over the summer.

Canopy Growth in June said it was being investigated by the Securities and Exchange Commission for material sales misstatements of BioSteel, which has partnerships with star athletes such as NFL quarterback Patrick Mahomes and the NBA's Luka Doncic.

The correction to the figures led to a decrease of roughly C$10 million in net sales for the year ended March 31, 2022, or roughly 2% of total sales.

Canopy is now working to keep its Canadian operations alive while it pursues its strategy to enter the U.S. market.

In July, Canopy Growth said it has reached agreements with its lenders to de-lever its balance sheet by C$437 million ($333.04 million) over the next six months and reduce annual interest costs by C$20 million to C$30 million.

Also read: Once-mighty Canopy Growth loses billions as dream of pot riches runs into reality of oversupply and overspending

-Steve Gelsi

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

September 14, 2023 10:58 ET (14:58 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.